Instem plc ("Instem")
US Government Contract
Further to the statement in the preliminary results announced on 28th March, the Company's auditors have confirmed that the accounting treatment for the contract with the US National Institute of Environmental Health Sciences (NIEHS) awarded in early 2017 will be to recognise the contract revenues and profits in the current year. This is consistent with the accounting treatment assumed in current market expectations.
For further information, please contact:
Instem plc |
Tel: +44 (0) 1785 825 600 |
Phil Reason, CEO |
www.instem.com |
Nigel Goldsmith, CFO |
|
|
|
N+1 Singer (Nominated Adviser & Broker) |
Tel: +44 (0) 20 7496 3000 |
Richard Lindley |
|
Nick Owen |
|
|
|
Walbrook PR Ltd |
Tel: +44 (0) 20 7933 8780 or |
Paul Cornelius |
instem@walbrookpr.com |
Helen Cresswell |
|
Sam Allen |
|
Paul Whittington
About Instem
Instem is a leading supplier of IT applications and services to the early development healthcare market delivering compelling solutions for data collection, analysis and regulatory submissions management. Instem solutions are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organisations for data-driven decision making leading to safer, more effective products.
Instem's portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonisation of actionable scientific information.
Instem supports over 500 clients through offices in the United States, United Kingdom, France, Japan, China and India.
To learn more about Instem solutions and its mission, please visit www.instem.com